The study of the level of awareness of pharmacists on vaccination against human papillomavirus and the role of pharmacists in the prevention of cervical cancer

Authors

DOI:

https://doi.org/10.24959/sphhcj.24.314

Keywords:

awareness; vaccination; human papillomavirus; cervical cancer; sociological study; pharmacist

Abstract

Aim. To study the awareness of pharmacists about vaccination against human papillomavirus (HPV) and the role of pharmacists in the prevention of cervical cancer.

Materials and methods. The results of a survey of pharmacists on vaccination against HPV and the role of pharmacists in the prevention of cervical cancer are presented. The data analysis is accompanied by the use of systematic, sociological (questionnaire survey) analysis, comparison and generalization.

Results. A pharmacist plays an important role in providing information to the public about human papillomavirus, vaccination against human papillomavirus and the risk of cervical cancer. According to the results of the survey, it has been determined that the majority of respondents consider it appropriate for pharmacists to participate in programs that will help to raise public awareness about the human papillomavirus, the importance of HPV vaccination and the risk of cervical cancer. However, only about 20 % of doctors provide this information to their patients, while almost 80 % do not. Low information awareness of the population has been identified as a key factor affecting vaccination readiness.

Conclusions. Based on the analysis, it has been found an insufficient level of knowledge about human papillomavirus among pharmacists to inform the population, as well as a lack of willingness to participate in activities aimed at raising public awareness about vaccination against papillomavirus.

References

Pujade-Lauraine, E., Tan, D. S. P., Leary, A., Mirza, M. R., Enomoto, T., Takyar, J. et al. (2022). Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review. Gynecologic Oncology, 167, 2. 360-372. doi: 10.1016/j.ygyno.2022.08.013.

World Health Organization (WHO). Available at: https://www.who.int/ru/news-room/fact-sheets/detail/cervical-cancer.

Olusola, P., Banerjee, H. N., Philley, J. V., Dasgupta, S. (2019). Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. Cells. 8(6), 622.

Fokom-Defo, V., Dille, I., Fokom-Domgue, J. (2024). Single dose HPV vaccine in achieving global cervical cancer elimination. Lancet Glob Health., 12(3), e360-e361.

Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M. et al. (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet, 395(10224), 591-603.

Dike-Ndudim J. N., Ayodeji S. O., Ndubueze C. W., Uwand C. U. (2022). Seroprevalence of Human Papillomavirus Type 16 Immunoglobulin G Antibodies (HPV 16-IgG) among Women Attending General Hospital Kagarko, Kagarko Lga, Kaduna State. International Journal of Pathogen Research, 9(2), 9-19. Available at: https://journalijpr.com/index.php/IJPR/article/view/151/301.

Dufour, L., Carrouel, F., & Dussart, C. (2023). Human Papillomaviruses in Adolescents: Knowledge, Attitudes, and Practices of Pharmacists Regarding Virus and Vaccination in France. Viruses, 15(3), 778. Available at: https://www.mdpi.com/1999-4915/15/3/778.

Shen, A. K., Peterson, A. (2020). The pharmacist and pharmacy have evolved to become more than the corner drugstore: A win for vaccinations and public health. Hum. Vaccines Immunother, 16, 1178–1180.

Hastings, T. J., Hohmann, L.A., McFarland, S. J., Teeter, B. S., Westrick, S. C. (2017). Pharmacists’ attitudes and perceived barriers to Human Papillomavirus (HPV) vaccination services. Pharmacy, 5, 45. doi: 10.3390/pharmacy5030045.

Ryan, G., Daly, E., Askelson, N., Pieper, F., Seegmiller, L., Allred T. (2020). Exploring opportunities to leverage pharmacists in rural areas to promote administration of Human Papillomavirus vaccine. Prev. Chronic Dis., 17, Е23. doi: 10.5888/pcd17.190351.

Berce, P. C., Bernstein, R. S., MacKinnon, G. E., Sorum, S., Martin, E., MacKinnon, K. J. et al. (2020). Immunizations at Wisconsin Pharmacies: Results of a statewide vaccine registry analysis and pharmacist survey. Vaccine, 38, 4448–4456. doi: 10.1016/j.vaccine.2020.04.043.

Islam, J. Y., Gruber, J. F., Kepka, D., Kunwar, M., Smith, S. B., Rothholz, M. C. et al. (2019). Pharmacist insights into adolescent Human Papillomavirus vaccination provision in the United States. Hum. Vaccines Immunother, 15, 1839–1850. doi: 10.1080/21645515.2018.1556077.

Calo, W. A., Gilkey, M. B., Shah, P., Marciniak, M. W., Brewer, N. T. (2017). Parents’ willingness to get Human Papillomavirus vaccination for their adolescent children at a pharmacy. Prev. Med.,99, 251–256.

Shah, P. D., Calo, W. A., Marciniak, M. W., Golin, C. E., Sleath, B. L., Brewer, N. T. (2018). Service quality and parents’ willingness to get adolescents HPV vaccine from pharmacists. Prev. Med., 109, 106–112.

Gilkey, M. B, Calo, W. A, Moss, J. L., Shah, P. D., Marciniak, M. W., Brewer, N. T. (2016). Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine, 34(9), 1187–1192. doi: 10.1016/j.vaccine.2016.01.023.

Daniel, C. L., Lawson, F., Vickers, M., Green, C., Wright, A., Coyne-Beasley, T. et al. (2021). Enrolling a rural community pharmacy as a Vaccines for Children provider to increase HPV vaccination: a feasibility study. BMC Public Health., 21(1), 1266. doi:10.1186/s12889-021-11304-8.

Bach, A. T., Goad, J. A. (2015). The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integr Pharm Res Pract., 4, 67-77. doi: 10.2147/IPRP.S63822.

Dingman, D., Schmit, C. D. (2018). Authority of pharmacists to administer human papillomavirus vaccine: alignment of state laws with age-level recommendations. Public Health Rep., 133(1), 55-63.

Nemchenko, A. S., Podhaina, M. V. (2009). Orhanizatsiino-ekonomichni pryntsypy farmatsevtychnoho zabezpechennia khvorykh na rak molochnoi zalozy : metod. rek. Kharkiv : FOP “Azamaieva V. P.”.

Nemchenko, A. S., Zharkova, S. O. (2013). Otsinka yakosti farmakoterapii khvorykh na rak shlunku ta priamoi kyshky : metod. rek. Kyiv.

Panfilova, H. L., Tsurikova, O. V. (2014). Obgruntuvannia zakhodiv z pidvyshchennia efektyvnosti farmatsevtychnoho zabezpechennia khvorykh na leikozy v Ukraini : metod. rek. Kyiv : Ukrainskyi tsentr naukovoi medychnoi informatsii ta patentno–litsenziinoi roboty.

Matushchak, M. R., Panfilova, H. L., Tereshchenko, L. V., Tsurikova, O. V., Boboshko, L. H. (2021). Rezultaty analizu likarskykh pryznachen ta struktury spozhyvannia preparativ khvorymy na limfohranulematoz v Ukraini. Sotsialna farmatsiia v okhoroni zdorovia, 7, 1, 24-35.

Islam, J. Y., Gruber, J. F., Kepka, D., Kunwar, M., Smith, S. B., Rothholz, M. C. et al. (2019). Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States. Human Vaccines & Immunotherapeutics, 15 (7-8), 1839-1850. Available at: https://www.tandfonline.com/doi/full/10.1080/21645515.2018.1556077.

Downloads

Published

2024-05-02

Issue

Vol. 10 No. 1 (2024)

Section

Social medicine and pharmacy: past, present and development prospects

License

Copyright (c) 2024 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).